Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Infant heart drug under the microscope: new study seeks answers

NCT ID NCT06613477

First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 32 times

Summary

This study looks at how the heart medication digoxin is processed by infants born with a single ventricle heart defect. Researchers will collect blood samples from 20 babies under 6 months old, either during routine care or through extra draws, to measure drug levels and heart function. The study does not change the baby's treatment plan and aims to better understand how digoxin works in this specific group.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFANT, PREMATURE, DISEASES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Duke University Medical Center

    RECRUITING

    Durham, North Carolina, 27701, United States

    Contact Email: •••••@•••••

  • Medical University of South Carolina

    NOT_YET_RECRUITING

    Charleston, South Carolina, 29425, United States

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.